About us

Committed to improving the lives of patients in Latin America

Valentech is a continuously evolving company that, since its creation, has been dedicated to seeking the most innovative therapies for patients in Latin America.

Our purpose

We are dedicated to safeguarding and improving the quality of life for users of the healthcare system. We achieve this by licensing, registering, importing and commercializing cutting-edge therapies that leverage the latest technology in the highly specialized market. Our commitment extends to monitoring patient support programs and pharmacovigilance initiatives, all aimed at delivering holistic, efficient, and enduring solutions to our stakeholders. Our approach is rooted in ethical and transparent practices.

Our team

Our organization takes pride in its team of highly experienced physicians specializing in orphan diseases. Their profound knowledge and expertise in this domain have significantly contributed to our position as one of the forefront companies in our industry today.


Achieve a prominent position in Latin America’s health technology sector, focusing on addressing pressing needs. We are dedicated to improving the quality of life for patients afflicted by orphan and highly specialized diseases. This commitment is upheld through our continuous improvement initiatives and a commitment to ethical and transparent actions. Leveraging our experience, capacity, and market knowledge, we empower our dedicated team to drive innovation and positive impact in healthcare.

Quality Policy

Through this Policy, Valentech Pharma Colombia SAS formalizes its commitment to consistently deliver innovation, quality and efficiency in the processes of acquiring licenses, importing and marketing highly specialized pharmaceutical products. This commitment includes adhering to all regulatory requirements and standards of ethical and transparent conduct. Our aim is to meet the needs and expectations of our stakeholders, contributing to the ongoing enhacement of the Quality Management System and the business culture.

Our History

Constant evolution

Valentech is a company in constant evolution, which since its creation has been looking for the most innovative therapies for patients in Latin America.



We began an important path in research by interacting with accredited laboratories and companies of international prestige.



Licensing and distribution agreements were entered into with industry partners in the United States, Europe and Asia.



We began the incorporation of companies throughout Latin America and the establishment of Valentech In.



We obtained the first sanitary registrations in Colombia.



We strengthened our marketing operations. We began operations in Colombia.



We opened our office in Brazil


Marketing Authorization

Obtained our first Marketing Authorization in Brazil



We consolidated more than 10 partnerships




We act with awareness of our nature, fostering admiration and understanding for ourselves and others.We embrace and accept differences of thought, recognizing that diverse perspectives can lead to agreements.


Conduct actions that uphold justice and integrity for oneself and others, confronting ongoing challenges and acknowledging that achieving results hinges on comprehensive and moral conduct throughout the process.


Demonstrating the capacity to devise and execute actions aligned with well-defined strategies and achievable, straightforawrd, and tangible goals. Upholding attitudes of continuous learning, resoluteness, and a readiness to address the demands of the business, customers, and society. Always bearing in mind that our purpose revolves around safeguarding and enhancing the quality of life for users of the healthcare system.


Execute all our projects with a sense of pride, unwavering commitment, dedicated effort, and a deep connection to the organization’s purpose. Recognizing the value of our identity, actions, and the individuals who journey with us as essential components for attaining our objectives and maintaining a trajectory of success.